Panagora Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Panagora Asset Management’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.12M	Buy	+451,868	New	+$8.55M	0.02%	368
2021 Q3	–	Sell	-1,341	Closed	-$104K	–	2314
2021 Q2	$104K	Sell	1,341 -3,265	-71%	-$248K	﹤0.01%	1891
2021 Q1	$343K	Buy	4,606 +1,817	+65%	+$168K	﹤0.01%	1501
2020 Q4	$475K	Sell	2,789 -2,369	-46%	-$351K	﹤0.01%	1246
2020 Q3	$724K	Buy	5,158 +272	+6%	+$41.3K	﹤0.01%	1018
2020 Q2	$783K	Buy	4,886 +4,060	+492%	+$552K	0.01%	1019
2020 Q1	$81K	Buy	+826	New	+$94.4K	﹤0.01%	1753
2019 Q3	–	Sell	-70	Closed	-$11K	–	2623
2019 Q2	$11K	Hold	70	–	–	﹤0.01%	2389
2019 Q1	$8K	Hold	70	–	–	﹤0.01%	2380
2018 Q4	$8K	Hold	70	–	–	﹤0.01%	2340
2018 Q3	$11K	Buy	+70	New	+$9.57K	﹤0.01%	2298
2016 Q1	–	Sell	-614	Closed	-$24K	–	2340
2015 Q4	$24K	Sell	614 -4,043	-87%	-$131K	﹤0.01%	2122
2015 Q3	$150K	Sell	4,657 -10,936	-70%	-$371K	﹤0.01%	1690
2015 Q2	$474K	Buy	+15,593	New	+$319K	﹤0.01%	1349

Other funds holding SRPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Panagora Asset Management's SRPT Position: Q2 2026 in Review

Panagora Asset Management opened a new position in Sarepta Therapeutics (SRPT) in Q2 2026: 451,868 shares worth $8.12M. The stake represents 0.02% of the portfolio and ranks #368 among its holdings. This is a return to the name: Panagora Asset Management previously reported a position in SRPT as recently as Q2 2021.

Panagora Asset Management first reported a position in SRPT in Q2 2015 and has held it in 14 quarters since. 324 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

Panagora Asset Management held 451,868 shares of Sarepta Therapeutics worth $8.12M as of Q2 2026.
Sarepta Therapeutics was a new Panagora Asset Management position in Q2 2026.
Sarepta Therapeutics made up 0.02% of Panagora Asset Management's portfolio in Q2 2026, its #368 holding.
Panagora Asset Management first reported a position in Sarepta Therapeutics in Q2 2015 and has held it in 14 quarters since.
324 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.